Patients are at the heart of everything we do. Sarah Cannon offers integrated cancer services, including oncology-trained nurse navigators, to patients from diagnosis through survivorship.
Sarah Cannon reaches more than 120,000 newly diagnosed cancer patients annually through our network across the United States and the United Kingdom, which allows our team to have the broadest perspective on cancer care delivery.
Sarah Cannon has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years. Our recognized physician leadership is at the forefront of shaping new standards of cancer care based upon the latest research.
Sarah Cannon provides patients with access to novel therapies through one of the largest early-phase clinical trial programs in the world. Physicians are armed with molecular profiling capabilities and clinical trial matching through our Personalized Medicine Program with GenoSpace.
Sarah Cannon's physician-led oversight drives quality standards and program development to build centers of excellence across cancer types.